STEEP HILL INC.SSTEEP HILL INC.

STEEP HILL INC.

0.025CADR
0.0000.00%
At close at 22:11 UTC
CAD
No trades
See on Supercharts

STPH fundamentals

Key facts

Market capitalization‪404.47 K‬CAD
Basic EPS (TTM)−0.01CAD
Founded2018
CEOSameet Kanade
About

Steep Hill, Inc. is a science and technology based global cannabis and hemp cannabinoids clone to consumer company. The corporation through its subsidiaries Canbud D580H124 Inc., Canbud D2385NR Inc., and Canbud D1726KC Inc holds three industrial hemp licenses for the purposes of supplying the global market with medicinal and wellness cannabidiol and other cannabinoid-based products. The company was founded by Mukesh Singh & Robert Tjandra on October 4, 2018 and is headquartered in Toronto, Canada.

Ownership
‪‪16.18 M‬‬
Free Float shares
‪‪15.82 M‬‬ (97.79%)
Closely held shares
‪‪356.81 K‬‬ (2.21%)
Free Float shares
‪‪15.82 M‬‬ (97.79%)
Closely held shares
‪‪356.81 K‬‬ (2.21%)
Capital structure
Market cap
‪‪404.47 K‬‬
Debt
‪‪3.46 K‬‬
Cash & equivalents
‪‪2.24 M‬‬
Enterprise value
‪‪−1.83 M‬‬

Valuation

Fundamental metrics to determine fair value of the stock

Summary
‪‪404.47 K‬‬
Price to earning ratio (P/E)
Price to sales ratio (P/S)
Market Cap
Net income
Revenue
Price to earning ratio (P/E)
Price to sales ratio (P/S)
Valuation ratios
‪0.00‬
‪0.25‬
‪0.50‬
‪0.75‬
‪1.00‬
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
‪0.00‬
‪0.20‬
‪0.40‬
‪0.60‬
‪0.80‬
P/E
P/S

Growth and Profitability

Company’s recent performance and margins

Performance
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
‪‪−900.00 K‬‬
‪‪−600.00 K‬‬
‪‪−300.00 K‬‬
‪0.00‬
‪‪300.00 K‬‬
Revenue
Net income
Net margin %
Revenue to profit conversion
Revenue
COGS
Gross profit
Op expenses
Op income
Non-Op income/ expenses
Taxes & Other
Net income
‪‪−42.00 K‬‬
‪‪−21.00 K‬‬
‪0.00‬
‪‪21.00 K‬‬
‪‪42.00 K‬‬
Revenue
COGS
Gross profit
Expenses & adjustments
Net income
‪‪−9.00 K‬‬
‪0.00‬
‪‪9.00 K‬‬
‪‪18.00 K‬‬
‪‪27.00 K‬‬

Dividends

Dividend yield, history and sustainability

STPH does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future

Financial health

Financial position and solvency of the company

Debt level and coverage
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
‪‪−700.00 K‬‬
‪‪−350.00 K‬‬
‪0.00‬
‪‪350.00 K‬‬
‪‪700.00 K‬‬
Debt
Free cash flow
Cash & equivalents
Financial position analysis
Short term
Long term
‪0.00‬
‪‪600.00 K‬‬
‪‪1.20 M‬‬
‪‪1.80 M‬‬
‪‪2.40 M‬‬
Assets
Liabilities